COPENHAGEN, May 13 (Reuters) - The Danish medicines agency on Monday warned of a supply shortage for two separate doses of Novo Nordisk's hugely popular weight loss drug Wegovy due to increasing demand. (Reporting by Louise Breusch Rasmussen, editing by Terje Solsvik)
Market Closed -
Other stock markets
|
After market 11:20:00 am | |||
915.7 DKK | -0.43% | 917.5 | +0.20% |
09:56pm | Sector Update: Health Care Stocks Fall Late Afternoon | MT |
09:13pm | Annual sales of weight-loss drugs seen hitting $150 billion | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.17% | 594B | |
+37.94% | 727B | |
-7.89% | 354B | |
+15.48% | 328B | |
-0.39% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.11% | 164B | |
-1.82% | 164B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Denmark faces Wegovy shortage due to rising demand, medicines agency says